Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
15/04/2026 01:34
April 15 (Reuters) - Mesoblast Ltd MSB.AX: MESOBLAST LTD-ACQUIRES CAR PLATFORM FOR PRECISION-ENHANCED CELL PRODUCTS ACQUIRES CAR PLATFORM FOR PRECISION-ENHANCED CELL PRODUCTS-MSB.AX TO INCORPORATE ENGINEERED CARS TO ENHANCE PRODUCT SPECIFICITY OBTAINS WORLDWIDE EXCLUSIVE RIGHTS TO CAR-MSC IP FROM MAYO CLINIC MAYO CLINIC TO PROVIDE IN-KIND SUPPORT AND GMP MANUFACTURING FOR CAR-MSC TECHNOLOGY Further company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil